DEUTSCHE BANK AG\ - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 17 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$138,000
+43.8%
30,313
+9.0%
0.00%
Q4 2018$96,000
-95.8%
27,803
-87.7%
0.00%
-100.0%
Q3 2018$2,271,000
+35.3%
225,395
-2.8%
0.00%
Q2 2018$1,678,000
+199.6%
231,831
+149.2%
0.00%
Q1 2018$560,000
+8.7%
93,034
+72.8%
0.00%
Q4 2017$515,000
+134.1%
53,827
+116.1%
0.00%
Q3 2017$220,000
-80.8%
24,904
-72.5%
0.00%
-100.0%
Q2 2017$1,144,000
+65.1%
90,522
+36.8%
0.00%0.0%
Q1 2017$693,000
-42.6%
66,155
-49.6%
0.00%0.0%
Q4 2016$1,207,000
-45.5%
131,379
-30.2%
0.00%
-50.0%
Q3 2016$2,216,000
+0.1%
188,106
+9.9%
0.00%0.0%
Q2 2016$2,214,000
+30.5%
171,143
+61.3%
0.00%
+100.0%
Q1 2016$1,696,000
-63.3%
106,108
-34.3%
0.00%
-66.7%
Q4 2015$4,624,000
+35.6%
161,556
+34.7%
0.00%0.0%
Q3 2015$3,410,000
-19.8%
119,914
+1.2%
0.00%0.0%
Q2 2015$4,254,000
+12.7%
118,478
+82.3%
0.00%
+50.0%
Q1 2015$3,776,000
+51.0%
64,990
+9.5%
0.00%0.0%
Q4 2014$2,501,000
+241.7%
59,335
+213.8%
0.00%
Q3 2014$732,000
+83.5%
18,911
+47.3%
0.00%
Q2 2014$399,000
-81.4%
12,837
-75.2%
0.00%
-100.0%
Q1 2014$2,147,000
+669.5%
51,844
+618.6%
0.00%
Q4 2013$279,000
-76.0%
7,215
-78.3%
0.00%
-100.0%
Q3 2013$1,163,00033,2840.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q2 2019
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 8,912,072$142,504,0002.66%
Antipodean Advisors LLC 342,294$5,473,0002.48%
JW Asset Management, LLC 221,538$3,542,0002.31%
Parametrica Management Ltd 33,562$537,0001.92%
12 West Capital Management LP 623,791$9,974,0001.39%
Folger Hill Asset Management LP 1,418,138$22,676,0001.27%
Bellevue Group AG 281,000$4,493,0000.82%
Plymouth Lane Capital Management, LLC 55,300$884,0000.78%
Orbimed Advisors 4,557,740$72,878,0000.77%
DIALECTIC CAPITAL MANAGEMENT, LP 79,550$1,272,0000.60%
View complete list of INSYS THERAPEUTICS INC NEW shareholders